Skip to main content
Remus Pharmaceuticals Limited (NSE: REMUS)
India flag India · Delayed Price · Currency is INR
2,452.35
+93.15 (3.95%)
At close: Dec 26, 2024

Remus Pharmaceuticals Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
 TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
 Sep '24 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20
Net Income
-215.3785.0334.3410.268.12
Depreciation & Amortization
-8.734.641.551.751.06
Other Amortization
-0.230.13---
Other Operating Activities
-20.53-3.93-1.72-0.660.85
Change in Accounts Receivable
--471.36-19.336.89-19.77-2.83
Change in Inventory
--6.2113.02-4.39-7.14-4.02
Change in Accounts Payable
-362.16-15.0714.9748.0121.13
Change in Other Net Operating Assets
--93.43-11.36-1.26-4.07-11.28
Operating Cash Flow
-36.0253.1350.3828.3813.03
Operating Cash Flow Growth
--32.20%5.46%77.52%117.86%-
Capital Expenditures
--6.36-27.32-0.71-0.66-5.59
Cash Acquisitions
--93.37----
Investment in Securities
--5.91-175.48-30.01-0.67-
Other Investing Activities
-22.353.452.440.69-
Investing Cash Flow
--89.43-151.92-45.45-30.9-5.59
Long-Term Debt Issued
--77.51--0.87
Long-Term Debt Repaid
--65.03--0.87-0.8-
Net Debt Issued (Repaid)
--65.0377.51-0.87-0.80.87
Issuance of Common Stock
-476.8542.5---
Common Dividends Paid
--5.89----
Other Financing Activities
--162.27-2.33-0.87-0.35-0.23
Financing Cash Flow
-243.66117.69-1.74-1.150.64
Miscellaneous Cash Flow Adjustments
--0-00
Net Cash Flow
-190.2618.93.18-3.688.08
Free Cash Flow
-29.6725.8149.6727.727.43
Free Cash Flow Growth
-14.93%-48.03%79.21%272.81%-
Free Cash Flow Margin
-1.39%5.72%20.09%14.74%5.99%
Free Cash Flow Per Share
-5.236.3212.426.931.86
Cash Interest Paid
-4.842.330.870.350.23
Cash Income Tax Paid
-65.6629.9711.943.653.05
Levered Free Cash Flow
--210.097.4542.8724.7-
Unlevered Free Cash Flow
--207.298.7343.3624.88-
Change in Net Working Capital
-384.6735.43-16.11-16.53-
Source: S&P Capital IQ. Standard template. Financial Sources.